BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pavan S, Prabhu AN, Prasad Gorthi S, Das B, Mutreja A, Shetty V, Ramamurthy T, Ballal M. Exploring the multifactorial aspects of Gut Microbiome in Parkinson's Disease. Folia Microbiol (Praha) 2022. [PMID: 35583791 DOI: 10.1007/s12223-022-00977-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Claudino dos Santos JC, Lima MPP, Brito GADC, Viana GSDB. ROLE OF ENTERIC GLIA AND MICROBIOTA-GUT-BRAIN AXIS IN PARKINSON DISEASE PATHOGENESIS. Ageing Research Reviews 2022. [DOI: 10.1016/j.arr.2022.101812] [Reference Citation Analysis]
2 Guzman-lopez EG, Reina M, Perez-gonzalez A, Francisco-marquez M, Hernandez-ayala LF, Castañeda-arriaga R, Galano A. CADMA-Chem: A Computational Protocol Based on Chemical Properties Aimed to Design Multifunctional Antioxidants. IJMS 2022;23:13246. [DOI: 10.3390/ijms232113246] [Reference Citation Analysis]
3 Pérez-gonzález A, Castañeda-arriaga R, Guzmán-lópez EG, Hernández-ayala LF, Galano A. Chalcone Derivatives with a High Potential as Multifunctional Antioxidant Neuroprotectors. ACS Omega. [DOI: 10.1021/acsomega.2c05518] [Reference Citation Analysis]
4 Magni G, Riboldi B, Petroni K, Ceruti S. Flavonoids bridging the gut and the brain: intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration. Biochem Pharmacol 2022;:115257. [PMID: 36179933 DOI: 10.1016/j.bcp.2022.115257] [Reference Citation Analysis]